While Agilon Health Inc has overperformed by 2.60%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AGL fell by -79.27%, with highs and lows ranging from $26.75 to $4.41, whereas the simple moving average fell by -57.95% in the last 200 days.
On April 22, 2024, Citigroup started tracking Agilon Health Inc (NYSE: AGL) recommending Neutral. A report published by Barclays on March 06, 2024, Initiated its previous ‘Underweight’ rating for AGL. TD Cowen also Downgraded AGL shares as ‘Market Perform’, setting a target price of $6.50 on the company’s shares in a report dated February 26, 2024. Jefferies February 26, 2024d the rating to Hold on February 26, 2024, and set its price target from $25 to $6.50. Wolfe Research January 08, 2024d its ‘Outperform’ rating to ‘Peer Perform’ for AGL, as published in its report on January 08, 2024. Leerink Partners also rated the stock as ‘Market Perform’.
Analysis of Agilon Health Inc (AGL)
Further, the quarter-over-quarter increase in sales is 53.10%, showing a positive trend in the upcoming months.
Agilon Health Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -23.40% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.51, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and AGL has an average volume of 4.95M. On a monthly basis, the volatility of the stock is set at 8.27%, whereas on a weekly basis, it is put at 6.24%, with a loss of -0.58% over the past seven days. Furthermore, long-term investors anticipate a median target price of $7.37, showing growth from the present price of $5.13, which can serve as yet another indication of whether AGL is worth investing in or should be passed over.
How Do You Analyze Agilon Health Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 26.31%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 85.33% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
AGL shares are owned by institutional investors to the tune of 85.33% at present.
